SOX17 Enables Immune Evasion of Early Colorectal Adenomas and Cancers

Researchers investigated how naive colon cancer organoids that were engineered in vitro to harbour Apc-null, KrasG12D and Trp53-null (AKP) mutations adapted to the in vivo native colonic environment.